LOS ANGELES--(BUSINESS WIRE)--Earlier this week, AIDS Healthcare Foundation (AHF) launched an awareness campaign to educate employees and neighbors of Gilead Sciences, Inc. about Gilead’s seeming rush to seek FDA approval of its blockbuster AIDS treatment Truvada as a form a ‘pre-exposure prophylaxis’ (PrEP) to prevent HIV transmission in uninfected individuals. The campaign, called, ‘Gilead: Squeezing Every Last Cent Out of Truvada!’ includes advocacy post cards printed with that message and sent to 48,000 homes in the Bay area as well as appearing as newspaper sticky note ads attached to the San Jose Mercury News and which are being distributed on editions of the paper from January 24th through January 29th.
